NM_001103.4:c.*526T>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001103.4(ACTN2):​c.*526T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.671 in 160,716 control chromosomes in the GnomAD database, including 37,030 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.67 ( 34642 hom., cov: 33)
Exomes 𝑓: 0.73 ( 2388 hom. )

Consequence

ACTN2
NM_001103.4 3_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.19

Publications

12 publications found
Variant links:
Genes affected
ACTN2 (HGNC:164): (actinin alpha 2) Alpha actinins belong to the spectrin gene superfamily which represents a diverse group of cytoskeletal proteins, including the alpha and beta spectrins and dystrophins. Alpha actinin is an actin-binding protein with multiple roles in different cell types. In nonmuscle cells, the cytoskeletal isoform is found along microfilament bundles and adherens-type junctions, where it is involved in binding actin to the membrane. In contrast, skeletal, cardiac, and smooth muscle isoforms are localized to the Z-disc and analogous dense bodies, where they help anchor the myofibrillar actin filaments. This gene encodes a muscle-specific, alpha actinin isoform that is expressed in both skeletal and cardiac muscles. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2013]
ACTN2 Gene-Disease associations (from GenCC):
  • intrinsic cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Laboratory for Molecular Medicine, ClinGen
  • myopathy, congenital, with structured cores and z-line abnormalities
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • dilated cardiomyopathy 1AA
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • heart conduction disease
    Inheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
  • myopathy, distal, 6, adult-onset, autosomal dominant
    Inheritance: AD, Unknown Classification: LIMITED Submitted by: Broad Center for Mendelian Genomics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 1-236763145-T-C is Benign according to our data. Variant chr1-236763145-T-C is described in ClinVar as Likely_benign. ClinVar VariationId is 296518.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.746 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001103.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACTN2
NM_001103.4
MANE Select
c.*526T>C
3_prime_UTR
Exon 21 of 21NP_001094.1
ACTN2
NR_184402.1
n.3583T>C
non_coding_transcript_exon
Exon 23 of 23
ACTN2
NM_001278343.2
c.*526T>C
3_prime_UTR
Exon 21 of 21NP_001265272.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACTN2
ENST00000366578.6
TSL:1 MANE Select
c.*526T>C
3_prime_UTR
Exon 21 of 21ENSP00000355537.4
ACTN2
ENST00000542672.7
TSL:1
c.*526T>C
3_prime_UTR
Exon 21 of 21ENSP00000443495.1
ACTN2
ENST00000461367.2
TSL:3
n.1507T>C
non_coding_transcript_exon
Exon 6 of 6

Frequencies

GnomAD3 genomes
AF:
0.668
AC:
101500
AN:
151958
Hom.:
34631
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.560
Gnomad AMI
AF:
0.897
Gnomad AMR
AF:
0.685
Gnomad ASJ
AF:
0.768
Gnomad EAS
AF:
0.448
Gnomad SAS
AF:
0.549
Gnomad FIN
AF:
0.640
Gnomad MID
AF:
0.687
Gnomad NFE
AF:
0.752
Gnomad OTH
AF:
0.658
GnomAD4 exome
AF:
0.730
AC:
6309
AN:
8640
Hom.:
2388
Cov.:
0
AF XY:
0.716
AC XY:
3265
AN XY:
4560
show subpopulations
African (AFR)
AF:
0.519
AC:
27
AN:
52
American (AMR)
AF:
0.749
AC:
1132
AN:
1512
Ashkenazi Jewish (ASJ)
AF:
0.760
AC:
38
AN:
50
East Asian (EAS)
AF:
0.478
AC:
176
AN:
368
South Asian (SAS)
AF:
0.601
AC:
641
AN:
1066
European-Finnish (FIN)
AF:
0.717
AC:
162
AN:
226
Middle Eastern (MID)
AF:
0.611
AC:
11
AN:
18
European-Non Finnish (NFE)
AF:
0.776
AC:
3900
AN:
5028
Other (OTH)
AF:
0.694
AC:
222
AN:
320
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.532
Heterozygous variant carriers
0
78
156
233
311
389
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.668
AC:
101550
AN:
152076
Hom.:
34642
Cov.:
33
AF XY:
0.659
AC XY:
49007
AN XY:
74332
show subpopulations
African (AFR)
AF:
0.560
AC:
23200
AN:
41460
American (AMR)
AF:
0.685
AC:
10477
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.768
AC:
2665
AN:
3470
East Asian (EAS)
AF:
0.448
AC:
2312
AN:
5162
South Asian (SAS)
AF:
0.548
AC:
2640
AN:
4818
European-Finnish (FIN)
AF:
0.640
AC:
6761
AN:
10570
Middle Eastern (MID)
AF:
0.690
AC:
203
AN:
294
European-Non Finnish (NFE)
AF:
0.752
AC:
51096
AN:
67988
Other (OTH)
AF:
0.651
AC:
1378
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1700
3400
5100
6800
8500
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
808
1616
2424
3232
4040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.727
Hom.:
66994
Bravo
AF:
0.670
Asia WGS
AF:
0.488
AC:
1698
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Hypertrophic cardiomyopathy Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
6.3
DANN
Benign
0.75
PhyloP100
1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1803032; hg19: chr1-236926445; API